Latest Breaking News On - Media relationse mail - Page 1 : comparemela.com

Novartis receives FDA approval for Fabhalta® (iptacopan), offering superior hemoglobin improvement in the absence of transfusions as the first oral monotherapy for adults with PNH

Novartis receives FDA approval for Fabhalta® (iptacopan), offering superior hemoglobin improvement in the absence of transfusions as the first oral monotherapy for adults with PNH
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

South koreaUnited statesFrance generalIsabella zinckNicole zinsli sommJulie masowRichard jarvisSamir shahParag mahantiImke kappesIptacopan monotherapyJonathan grahamZain iqbalSloan simpsonMichael meomarlena abdinoorAnn hematol

Novartis presents new long-term Leqvio® (inclisiran) data demonstrating consistent efficacy and safety beyond six years

Results from the ORION-8 open-label extension trial show twice-yearly Leqvio, in addition to statin therapy, provides consistent low-density lipo.

United statesSouth koreaNoord hollandDavid soergelNovartis leqvioSloan simpsonMichael meo marlena abdinoorColl cardiolJulie masowLos angelesNorman leporMetabolic drug developmentExchange commissionPublic healthCongress onNovartis pharmaceuticals corporation

Novartis highlights scientific advances with Kisqali, iptacopan, Scemblix and YTB323 data at SABCS and ASH

First data to be presented as a late-breaker abstract from global pivotal APPLY-PNH trial of investigational oral monotherapy iptacopan in paroxys.

United statesEast hanoverAmerica julie masowJeff legosMichael meoMary carmichaelPrnewswire novartisAmerica sloan simpsonNovartis institutes for biomedical researchMarrow transplant researchAstex pharmaceuticalsInternational bloodExchange commissionGlobal head of oncology hematology developmentAmerican society of hematologyNj novartis pharmaceuticals corporation

FDA approves Novartis Kymriah® CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma

FDA approves Novartis Kymriah® CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJulie masowJamie bennettStephenj schusterMeghan gutierrezSloan simpsonVictor bultoLymphoma programPerelman school of medicineAmerican society of hematologyUniversity of pennsylvania abramson cancer centerEuropean unionTranslational researchLymphoma research foundationFollicular lymphoma international prognostic indexDrug administration